Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Optional)
Grant Opportunity Analysis
The National Institutes of Health (NIH) is offering a funding opportunity for High Impact Specialized Innovation Programs in Clinical and Translational Science, aimed at enhancing the capabilities and resources of Clinical and Translational Science Awards (CTSA) Program Hubs. This initiative seeks to address critical gaps and barriers in clinical and translational research, promoting innovative solutions that can lead to improved health outcomes. Eligible applicants, primarily UM1 CTSA hubs, can propose projects with budgets up to $500,000 per year for a duration of up to five years, with the first application deadline set for December 12, 2023. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-054.html.
Eligible Applicants
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See full Notice of Funding Opportunity for additional details on eligibility.